🎄 Christmas Sale15% off every vialPrices already reduced · applied automatically at checkout · ends Dec 26 · excludes Subscribe & SaveShop the sale →
Laboratory research materials only · Research purchaser verification required
My account ↗

GHK-Cu research: copper peptides, skin formulations and evidence

GHK-Cu is the copper complex associated with the tripeptide glycyl-histidyl-lysine. “Copper peptides” is a broader phrase. It does not guarantee that two products have the same composition, formulation, delivery characteristics or evidence.

Hebrew searches may describe GHK-Cu as פפטיד נחושת or פפטידי נחושת. Those broad phrases can lead to skincare, finished products or laboratory materials. First establish which product form the question concerns.

An ingredient name is not a finished-product specification

An ingredient name is not a finished-product specification
DescriptionWhat to identifyEvidence needed
GHKThe named tripeptideChemical identity and form
GHK-CuThe copper-associated complex, not just a blue colorIdentity, composition and appropriate analytical results
A cosmetic serum containing copper peptidesThe complete formulation and its intended cosmetic useEvidence for that formulation; not a separate powder
A laboratory vialThe exact material, quantity and supplied lotThe matching batch report and research specification

Common questions

Is GHK-Cu the same as every copper-peptide serum?

No. GHK-Cu names a complex; a serum is a formulation with its own concentration, ingredients and evidence. Shared ingredient wording does not make a laboratory vial a finished skincare product.

Does blue color verify GHK-Cu quality?

No. Appearance cannot establish peptide identity, measured content, purity or the authenticity of a lot report. Use the original analytical record and check the actual material and sample identifiers.

What the primary experiments actually tested

GHK-Cu: model, result and transferability
PublicationModel / formulation contextMeasured observationEvidence limitation
Maquart et al. · 1988Laboratory fibroblast cultures; GHK-Cu complexCollagen synthesis increased under the experimental conditions.Cell-culture concentrations are not a tested percentage in a finished serum; no human wrinkle or hair outcome was established.
Maquart et al. · 1993Animal; experimental wound chambers in ratsConnective-tissue accumulation and collagen-related measures increased.Experimental wounds and local exposure in rats cannot establish efficacy of a cosmetic or an injectable retail material in humans.
Hostynek et al. · 2010Ex vivo; separated layers of human skin, copper-tripeptide diacetateCopper retention and passage differed with the skin preparation.Copper measurement is not necessarily intact GHK-Cu measurement: ligand exchange and barrier preparation matter. No clinical benefit was measured.
Li et al. · 2015Laboratory skin-delivery models, including human skin; microneedle pretreatmentOver 9 hours, treated human skin allowed 134 ± 12 nmol peptide and 705 ± 84 nmol copper through; intact skin showed almost none under these conditions.A delivery experiment, not a facial-serum efficacy trial. The two analytes differ. No at-home microneedling or injection recommendation follows.

These are mechanistic, animal or ex vivo studies—not randomized evidence for a particular facial serum. Human cosmetic claims often cite small formulation studies through reviews or conference summaries. Without the actual protocol, formula, comparator and complete report, we do not assign a clinical effect size or call a retail vial clinically proven. Hair-growth and systemic-recovery claims require their own direct evidence.

A percentage is meaningful only with its denominator

Concentrations and formulations cannot be swapped by name
Reported unit / materialWhat must be specifiedWhat cannot be inferred
mol/L or nmol/L in cultureChemical form, complexation, medium and exposure timeNot a percentage in a skin-care product or a human-use recommendation.
% w/w of finished formulaMass of active GHK-Cu per total formula mass; distinguish an ingredient-solution percentageA “1% complex” marketing claim need not mean 1% pure active peptide.
mg/vial laboratory materialBatch identity, counterion/water, content method and intended assayDoes not supply a tested topical concentration, preservative system, stability or skin compatibility.
Copper versus intact peptideWhich species the method detects; ligand exchange and assay selectivityCopper penetration alone does not prove intact GHK-Cu delivery.

Vehicle, pH, packaging, oxidation, peptide–copper binding, other ingredients and storage stability affect a finished formula. We have not verified a single clinically optimal GHK-Cu percentage from the primary sources reviewed. Where a study does not supply the exact active concentration, leave it unreported rather than borrow a supplier’s formula. This guide is not a formulation, mixing or administration protocol.

Choose the source that fits the question

For פפטידי נחושת לעור or a GHK-Cu serum question, seek evidence for the complete cosmetic formulation and a qualified skin-care professional where appropriate. For laboratory GHK-Cu research, check the specified complex, batch, analytical methods and model. Neither route supplies evidence for an unrelated injectable product.

Primary sources and verification records

Illustrative laboratory vials forming the Locked Aminos wordmark
Illustration only, not evidence of a tested batch.

Separate the ingredient from the finished formulation

A topical cosmetic formula contains more than a named peptide. Concentration, vehicle, stability and delivery affect what is being studied. A laboratory powder is not that finished formulation. Results from a cosmetic study cannot be transferred to another route or a separate vial merely because both labels mention GHK-Cu.

How to read the biological literature

The literature explores GHK-Cu in cellular signaling and tissue-remodeling contexts. For any claimed effect, identify the actual experiment, material and endpoint. Mechanistic observations and reviews are useful for forming research questions. They are not independent confirmation that a retail product improves skin, hair or systemic health.

Quality and safety are separate assessments

Verify the stated complex, chemical form, batch and method on the certificate. Copper content, peptide identity and chromatographic purity are not interchangeable measurements. FDA discussion of injectable GHK-Cu highlights route-specific safety concerns; it should not be reinterpreted as approval of a different product or exposure route.

Which page should a search lead to?

A skincare question calls for evidence about the actual cosmetic formula. A laboratory procurement question calls for identity and batch documentation. A personal treatment question calls for qualified medical guidance. Keeping those routes distinct prevents broad copper-peptide searches from becoming misleading recommendations for research materials.

Sources and review scope

Sources explain terminology and evidence limits. They are not commercial endorsements or approvals of catalog products. Check the original source for updates.

Catalog identity and documentation

These links identify laboratory materials, not treatments or clinical-trial products.